NASDAQ / NYSE / AMEX CLCD - we posted positive news about its Phase 3 drug study as soon as it hit at 7:48 am on Tuesday morning, September 6th, at $14.11/share. CLCD gapped up huge from the news all the way to $19.50/share then...
NASDAQ / NYSE / AMEX REN was a great trade idea going at the end of August after consolidating in the low $16 range. The ticker which has been a big play for us since the upper $4s in July worked its way up towards...
NASDAQ / NYSE / AMEX REN was a great trade idea going into last week after consolidating in the low $16 range. The ticker which has been a big play for us since the upper $4s in July worked its way up towards $17 early...
NASDAQ / NYSE / AMEX REN was a great trade idea coming into the week after consolidating in the low $16 range. The ticker which has been a big play for us since the upper $4s in July worked its way up towards $17 early...
NASDAQ / NYSE / AMEX XCOM which offered us a nice 100%+ move in July followed by another 80% move earlier this month had fallen to new lows in the $.30s following some bad news about a cancelled agreement on Monday evening. The big drop...
NASDAQ / NYSE / AMEX STEM which we put on our Low Float Big Board ticker list at the start of the summer, offered us a nice move in early May, but has had a rough past few weeks teetering on Bankruptcy and seeing its share...
NASDAQ / NYSE / AMEX EBIO - this ticker originally got our attention back on April 14th in the low $.50s with its most recent new trade opportunity coming on July 6th at $2.00/share. EBIO has continued to impress hitting new highs again this week...
